Posts Tagged "AstraZeneca"

Indian Patent Office rejects compulsory license application for AstraZeneca’s Saxagliptin

Compulsory license application for AstraZeneca’s Saxagliptin Patents are generally granted to encourage inventions and to protect the rights of the inventor. However, the Indian Patent Act serves to strike a balance between protecting the rights of the inventor and making

Read More